Miguel A. Escobar

3.6k total citations
120 papers, 1.8k citations indexed

About

Miguel A. Escobar is a scholar working on Hematology, Cardiology and Cardiovascular Medicine and Genetics. According to data from OpenAlex, Miguel A. Escobar has authored 120 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Hematology, 18 papers in Cardiology and Cardiovascular Medicine and 16 papers in Genetics. Recurrent topics in Miguel A. Escobar's work include Hemophilia Treatment and Research (69 papers), Platelet Disorders and Treatments (30 papers) and Blood Coagulation and Thrombosis Mechanisms (23 papers). Miguel A. Escobar is often cited by papers focused on Hemophilia Treatment and Research (69 papers), Platelet Disorders and Treatments (30 papers) and Blood Coagulation and Thrombosis Mechanisms (23 papers). Miguel A. Escobar collaborates with scholars based in United States, Spain and Italy. Miguel A. Escobar's co-authors include Guy Young, Richard B. Weiskopf, Harold R. Roberts, Dougald M. Monroe, Luigi Piero Solimeno, Meera Chitlur, Sabah Sallah, Nancy Gore Saravia, Diane J. Nugent and Gilbert White and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Miguel A. Escobar

107 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Miguel A. Escobar United States	24	877	324	284	183	181	120	1.8k
Katerina Pavenski Canada	21	970 1.1×	157 0.5×	160 0.6×	421 2.3×	145 0.8×	103	2.2k
Linda Jacobson United States	22	837 1.0×	291 0.9×	208 0.7×	104 0.6×	198 1.1×	42	1.5k
François Forestier France	22	352 0.4×	137 0.4×	160 0.6×	115 0.6×	246 1.4×	44	2.1k
Richard A. Marlar United States	33	1.7k 2.0×	697 2.2×	295 1.0×	274 1.5×	436 2.4×	104	2.9k
K. K. Hampton United Kingdom	19	764 0.9×	272 0.8×	85 0.3×	200 1.1×	157 0.9×	42	1.3k
I.R.O. Nováková Netherlands	21	983 1.1×	150 0.5×	144 0.5×	255 1.4×	125 0.7×	52	1.6k
D. C. Heaton New Zealand	20	572 0.7×	136 0.4×	188 0.7×	294 1.6×	149 0.8×	45	1.3k
Michael D. Tarantino United States	31	1.9k 2.2×	179 0.6×	190 0.7×	289 1.6×	494 2.7×	127	2.6k
A.N. Whitaker Australia	21	501 0.6×	300 0.9×	155 0.5×	63 0.3×	281 1.6×	39	1.5k
Amparo Santamaría Spain	18	350 0.4×	217 0.7×	74 0.3×	106 0.6×	137 0.8×	86	937

Countries citing papers authored by Miguel A. Escobar

Since Specialization

Citations

This map shows the geographic impact of Miguel A. Escobar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miguel A. Escobar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miguel A. Escobar more than expected).

Fields of papers citing papers by Miguel A. Escobar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miguel A. Escobar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miguel A. Escobar. The network helps show where Miguel A. Escobar may publish in the future.

Co-authorship network of co-authors of Miguel A. Escobar

This figure shows the co-authorship network connecting the top 25 collaborators of Miguel A. Escobar. A scholar is included among the top collaborators of Miguel A. Escobar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miguel A. Escobar. Miguel A. Escobar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Srivaths, Lakshmi, Joanna G. Larson, Sepideh Saroukhani, et al.. (2024). Comparing one stage, chromogenic assay results and discrepancies with bleeding phenotype and genetic variants in females with hemophilia A. Journal of Thrombosis and Haemostasis. 23(2). 504–512. 2 indexed citations

Drygalski, Annette von, Aric Parnes, Evan C. Chen, et al.. (2024). Real-world impact of emicizumab and immunosuppression on acquired hemophilia A: a multicenter US cohort. Blood Advances. 8(22). 5896–5905. 1 indexed citations

Pabinger, Ingrid, Miguel A. Escobar, Barbara A. Konkle, et al.. (2024). Multicenter assessment and longitudinal study of the prevalence of antibodies and related adaptive immune responses to AAV in adult males with hemophilia. Gene Therapy. 31(5-6). 273–284. 9 indexed citations

Escobar, Miguel A., et al.. (2023). A real-world evidence analysis of the impact of switching from factor VIII to emicizumab prophylaxis in patients with hemophilia A without inhibitors. Expert Review of Hematology. 16(6). 467–474. 6 indexed citations

Escobar, Miguel A., et al.. (2023). Impact of switching prophylaxis treatment from factor VIII to emicizumab in hemophilia A patients without inhibitors. Journal of Medical Economics. 26(1). 574–580. 1 indexed citations

Manon‐Jensen, Tina, Srilatha Tangada, Cecilie L. Bager, et al.. (2023). Evaluation of collagen turnover biomarkers as an objective measure for efficacy of treatment with rurioctocog alfa pegol in patients with hemophilia A: a secondary analysis of a randomized controlled trial. Journal of Thrombosis and Haemostasis. 22(1). 90–100. 4 indexed citations

Flueck, Werner T., Miguel A. Escobar, Valerius Geist, et al.. (2022). Loss of Migratory Traditions Makes the Endangered Patagonian Huemul Deer a Year-Round Refugee in Its Summer Habitat. SHILAP Revista de lepidopterología. 2(2). 322–348. 7 indexed citations

Cuker, Adam, Miguel A. Escobar, M. Elaine Eyster, et al.. (2022). Postoperative bleeding complications in patients with hemophilia undergoing major orthopedic surgery: A prospective multicenter observational study. Journal of Thrombosis and Haemostasis. 20(4). 857–865. 21 indexed citations

Denning, Gabriela, Ángel A. Rivera, Miguel A. Escobar, et al.. (2021). F5‐Atlanta: A novel mutation in F5 associated with enhanced East Texas splicing and FV‐short production. Journal of Thrombosis and Haemostasis. 19(7). 1653–1665. 14 indexed citations

10.

Konkle, Barbara A., Christopher Walsh, Miguel A. Escobar, et al.. (2020). BAX 335 hemophilia B gene therapy clinical trial results: potential impact of CpG sequences on gene expression. Blood. 137(6). 763–774. 138 indexed citations

11.

Samuel, Sophie, Mary F. McGuire, Jennifer Cortes, et al.. (2019). Comparison of polyspecific versus IgG specific ELISA in predominately cardiac patients with suspected heparin induced thrombocytopenia. Journal of Thrombosis and Thrombolysis. 49(1). 27–33. 1 indexed citations

12.

Denning, Gabriela, Ángel A. Rivera, Miguel A. Escobar, et al.. (2017). Factor V Atlanta: A Novel Mutation in the F5 Gene Reveals Potential New Cis-Acting Elements Involved in Regulating FV-Short and TFPI Levels. Blood. 130. 366–366. 5 indexed citations

13.

Escobar, Miguel A., Ramin Tehranchi, Faraizah Abdul Karim, et al.. (2016). Low‐factor consumption for major surgery in haemophilia B with long‐acting recombinant glycoPEGylated factor IX. Haemophilia. 23(1). 67–76. 21 indexed citations

14.

Escobar, Miguel A., et al.. (2016). Prognosis of heart failure with preserved ejection fraction treated with β-blockers: A propensity matched study in the community. International Journal of Cardiology. 222. 594–602. 12 indexed citations

15.

Samuel, Sophie, et al.. (2016). Antifactor Xa levels vs. activated partial thromboplastin time for monitoring unfractionated heparin. A pilot study. Journal of Clinical Pharmacy and Therapeutics. 41(5). 499–502. 39 indexed citations

16.

Escobar, Miguel A. & Sabah Sallah. (2013). Hemophilia A and hemophilia B: focus on arthropathy and variables affecting bleeding severity and prophylaxis. Journal of Thrombosis and Haemostasis. 11(8). 1449–1453. 31 indexed citations

17.

Escobar, Miguel A., et al.. (2008). Mortality and morbidity of newly diagnosed heart failure treated with statins. International Journal of Cardiology. 140(2). 210–218. 13 indexed citations

18.

Planque, Stephanie, Yukie Mitsuda, Hiroaki Taguchi, et al.. (2007). Characterization of gp120 Hydrolysis by IgA Antibodies from Humans without HIV Infection. AIDS Research and Human Retroviruses. 23(12). 1541–1554. 29 indexed citations

19.

Souza, Jonas A. de & Miguel A. Escobar. (2006). Rituximab as a Treatment Option for Acquired Inhibitors.. Blood. 108(11). 4065–4065. 2 indexed citations

20.

Escobar, Miguel A.. (1977). [Therapy of acute lymphocytic leukaemia in children. Assessment of a cooperative trial (author's transl)].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 22(3). 304–12. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact